The Influence of Race and MitoQ Supplementation on Skin Perfusion in the Cold

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Individuals who operate in cold weather are at risk of developing cold injuries, for example, frostbite. They also often experience a loss of hand function and joint mobility due to a decrease in skin temperature and blood flow. In addition, the risk of getting a cold injury is higher in the Black population compared to other racial and ethnic groups. Increases in oxidant compounds can cause the blood vessels in the skin to narrow and decrease skin temperature in the cold. However, it is unknown whether the higher risk of cold injury in Black individuals is because of a greater amount of oxidant compounds in the blood vessels. The purpose of this research is to see if an antioxidant supplement called MitoQ can help to improve skin temperature and blood flow in the cold and if the improvement is greater in Black individuals.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: t
View:

• Male or female, age 18-40

• In good health as determined by OMSO (Office of Medical Support and Oversight)

• Willing to refrain from exercise and caffeinated or alcoholic beverages for 12 hours before each testing session

• Willing to refrain from antioxidant-rich foods, such as blueberries, pecans, and dark chocolate, 48 h before each testing session

• Eumenorrheic females (menstrual cycle length between 24-35 days) or females taking oral contraceptives, or utilizing implantable contraception (e.g., intrauterine device)

• Have supervisor approval if active-duty military or a federal employee at NSSC

Locations
United States
Massachusetts
U.S. Army Research Institute of Environmental Medicine
RECRUITING
Natick
Contact Information
Primary
Billie Alba, Ph.D.
billie.k.alba.civ@health.mil
508-206-2171
Time Frame
Start Date: 2024-09-16
Estimated Completion Date: 2025-09-30
Participants
Target number of participants: 30
Treatments
Placebo_comparator: Placebo - Cold Water Hand Immersion
Four placebo (microcrystalline cellulose) capsules are taken \~1 hour before a 30-minute hand immersion in 54°F water.
Placebo_comparator: Placebo - Cold Air Exposure
Four placebo (microcrystalline cellulose) capsules are taken \~1 hour before a 90-minute cold exposure in 41°F air.
Experimental: MitoQ - Cold Water Hand Immersion
Four 20 mg MitoQ capsules (80 mg total) are taken \~1 hour before a 30-minute hand immersion in 54°F water.
Experimental: MitoQ - Cold Air Exposure
Four 20 mg MitoQ capsules (80 mg total) are taken \~1 hour before a 90-minute cold exposure in 41°F air.
Related Therapeutic Areas
Sponsors
Leads: United States Army Research Institute of Environmental Medicine

This content was sourced from clinicaltrials.gov